Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 4
1948 3
1949 1
1953 13
1954 19
1955 14
1956 51
1957 77
1958 62
1959 62
1960 59
1961 40
1962 39
1964 6
1965 88
1966 198
1967 227
1968 247
1969 259
1970 278
1971 316
1972 359
1973 305
1974 306
1975 292
1976 277
1977 260
1978 227
1979 261
1980 256
1981 243
1982 222
1983 290
1984 291
1985 351
1986 324
1987 337
1988 303
1989 325
1990 343
1991 312
1992 260
1993 275
1994 301
1995 311
1996 340
1997 342
1998 407
1999 393
2000 392
2001 488
2002 475
2003 508
2004 633
2005 913
2006 973
2007 1080
2008 1122
2009 1177
2010 1222
2011 1348
2012 1479
2013 1584
2014 1668
2015 1758
2016 1762
2017 1738
2018 1712
2019 947
2020 36
Text availability
Article attribute
Article type
Publication date

Search Results

30,636 results
Results by year
Filters applied: . Clear all
Page 1
Edaravone: a new hope for deadly amyotrophic lateral sclerosis.
Bhandari R, Kuhad A, Kuhad A. Bhandari R, et al. Drugs Today (Barc). 2018 Jun;54(6):349-360. doi: 10.1358/dot.2018.54.6.2828189. Drugs Today (Barc). 2018. PMID: 29998226 Review.
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.
Khandelwal P, Teusink-Cross A, Davies SM, Nelson AS, Dandoy CE, El-Bietar J, Marsh RA, Kumar AR, Grimley MS, Jodele S, Myers KC. Khandelwal P, et al. Biol Blood Marrow Transplant. 2017 Jul;23(7):1122-1127. doi: 10.1016/j.bbmt.2017.03.029. Epub 2017 Mar 23. Biol Blood Marrow Transplant. 2017. PMID: 28344057 Free article.
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.
Verstovsek S, Passamonti F, Rambaldi A, Barosi G, Rumi E, Gattoni E, Pieri L, Zhen H, Granier M, Assad A, Cazzola M, Kantarjian HM, Barbui T, Vannucchi AM. Verstovsek S, et al. Blood. 2017 Oct 12;130(15):1768-1771. doi: 10.1182/blood-2017-02-765032. Epub 2017 Aug 21. Blood. 2017. PMID: 28827411 Free PMC article. Clinical Trial. No abstract available.
Pharmacological characteristics of metamizole.
Jasiecka A, Maślanka T, Jaroszewski JJ. Jasiecka A, et al. Pol J Vet Sci. 2014;17(1):207-14. doi: 10.2478/pjvs-2014-0030. Pol J Vet Sci. 2014. PMID: 24724493 Review.
The EXXERT Study.
Thompson RC, Thomas GS. Thompson RC, et al. J Nucl Cardiol. 2017 Oct;24(5):1800-1802. doi: 10.1007/s12350-017-0903-2. Epub 2017 May 23. J Nucl Cardiol. 2017. PMID: 28537038 Clinical Trial. No abstract available.
Effects of dipyrone on the digestive tract.
Collares EF, Troncon LEA. Collares EF, et al. Braz J Med Biol Res. 2019 Jan 10;52(2):e8103. doi: 10.1590/1414-431X20188103. Braz J Med Biol Res. 2019. PMID: 30652827 Free PMC article. Review.
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists.
Shi J, Gu Z, Jurica EA, Wu X, Haque LE, Williams KN, Hernandez AS, Hong Z, Gao Q, Dabros M, Davulcu AH, Mathur A, Rampulla RA, Gupta AK, Jayaram R, Apedo A, Moore DB, Liu H, Kunselman LK, Brady EJ, Wilkes JJ, Zinker BA, Cai H, Shu YZ, Sun Q, Dierks EA, Foster KA, Xu C, Wang T, Panemangalore R, Cvijic ME, Xie C, Cao GG, Zhou M, Krupinski J, Whaley JM, Robl JA, Ewing WR, Ellsworth BA. Shi J, et al. J Med Chem. 2018 Feb 8;61(3):681-694. doi: 10.1021/acs.jmedchem.7b00982. Epub 2018 Jan 27. J Med Chem. 2018. PMID: 29316397
A Drug Eluting Scaffold for the Treatment of Arthrofibrosis.
Trousdale WH, Salib CG, Reina N, Lewallen EA, Viste A, Berry DJ, Morrey ME, Sanchez-Sotelo J, van Wijnen AJ, Abdel MP. Trousdale WH, et al. Tissue Eng Part C Methods. 2018 Sep;24(9):514-523. doi: 10.1089/ten.TEC.2018.0136. Tissue Eng Part C Methods. 2018. PMID: 30101668 Free PMC article.
30,636 results
Jump to page
Feedback